Delivery Order SPE2DB20D1100-SPE2DB24FA3F8
Award Date 2/20/24
Potential Completion Date 2/21/24
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XCOPRI 200 MG TABLET 30S. The contract has a completion date of January 30, 2024, and a potential value of $1,701.81. Amerisourcebergen Drug Corp, a for-profit organization, has received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and related...
- The Defense Logistics Agency (DLA) awarded a $1,623.99 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XCOPRI 100 MG TABLET 30S. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563850465 - XCOPRI 100 MG TABLET 30S. The $1,242.66 contract has a performance period through March 5, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is providing pharmaceutical products and medical supplies to support military treatment programs and facilities under this delivery order. Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a quantity of 30 tablets of the pharmaceutical drug XCOPRI 50 MG. The delivery order has a potential value of $1,082.66 and a completion date of February 15, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product XCOPRI 50 MG TABLET 30S, with a ceiling value of $3,257.73 and a performance period through March 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $1,623.99 worth of XCOPRI 100 MG TABLET 30S. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count supply) with a contract value of $1,768.44 under a firm fixed-price arrangement. The award, made on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a non-competitive, direct delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XCOPRI 100 MG TABLET 30S. The $3,247.98 contract has a completion date of March 1, 2024 and was awarded on February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is part of Amerisourcebergen Drug Corp's existing...
- The Defense Logistics Agency (DLA) awarded a $1,623.99 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XCOPRI 200 MG TABLET 30S. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which enables the agency to efficiently procure a range of essential medical commodities to support military treatment programs...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,794.10 to AmerisourceBergen Drug Corp for XCOPRI 150 mg tablets (30-count supply) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running...